6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Hyperlipemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Katselou, MG; Kourounakis, AP; Matralis, AN; Nikitakis, A | 1 |
| Athanasekou, C; Rekka, EA; Theodosis-Nobelos, P | 1 |
| Kourounakis, PN; Papagiouvannis, G; Rekka, EA; Theodosis-Nobelos, P | 1 |
| Kourounakis, A; Lambrinidis, G; Tzara, A | 1 |
| Demer, LL; Garcia, J; Iriana, S; Kalajzic, I; Li, X; Lu, J; Rowe, D; Tintut, Y | 1 |
| Bell, HK; Bloomer, RJ | 1 |
| Holst, JJ; Kappe, C; Sjöholm, A; Zhang, Q | 1 |
7 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Hyperlipemia
| Article | Year |
|---|---|
Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents.
Topics: Animals; Antioxidants; Atherosclerosis; Benzoxazines; Cholesterol, LDL; Farnesyl-Diphosphate Farnesyltransferase; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Peroxidation; Mice; Rats; Thiazines | 2011 |
Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Antioxidants; Butanes; Carrageenan; Chemical and Drug Induced Liver Injury; Cysteine; Edema; Free Radicals; Hyperlipidemias; Lipid Peroxidation; Oxidative Stress; Parabens; Protective Agents; Rats | 2017 |
Active Anti-Inflammatory and Hypolipidemic Derivatives of Lorazepam.
Topics: Acrylates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Carrageenan; Chromans; Humans; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Lipid Peroxidation; Lipoxygenase Inhibitors; Lorazepam; Oxidative Stress; Rats; Thioctic Acid | 2019 |
Design of Multifaceted Antioxidants: Shifting towards Anti-Inflammatory and Antihyperlipidemic Activity.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Chromans; Drug Design; Humans; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Lipoxygenase; Lipoxygenase Inhibitors; Molecular Docking Simulation; Nerve Degeneration; Oxidative Stress; Parabens; Structure-Activity Relationship | 2021 |
Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.
Topics: Animals; Cells, Cultured; Chromans; Female; Green Fluorescent Proteins; Hyperlipidemias; Inflammation; Mice; Mice, Mutant Strains; Mice, Transgenic; Osteoblasts; Osteocytes; Parathyroid Hormone; Reactive Oxygen Species; Receptor, Parathyroid Hormone, Type 1; Receptors, LDL | 2014 |
Impact of serum estradiol on postprandial lipemia, oxidative stress, and inflammation across a single menstrual cycle.
Topics: Adolescent; Adult; Analysis of Variance; Antioxidants; Area Under Curve; C-Reactive Protein; Chromans; Dietary Fats; Energy Intake; Estradiol; Female; Follicular Phase; Humans; Hydrogen Peroxide; Hyperlipidemias; Inflammation; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Oxidative Stress; Postprandial Period; Tennessee; Time Factors; Triglycerides | 2010 |
Molecular mechanisms of lipoapoptosis and metformin protection in GLP-1 secreting cells.
Topics: Animals; Antioxidants; Apoptosis; Caspase 3; Cell Line; Chromans; Cytoprotection; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Hyperlipidemias; Hypoglycemic Agents; MAP Kinase Kinase 3; MAP Kinase Kinase 4; MAP Kinase Kinase 6; Metformin; Mice; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Palmitates; Reactive Oxygen Species | 2012 |